BackGeneral Biologicals Overview

General Biologicals Accounts Payable

Track General Biologicals's accounts payable ($67M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$66.98M
↑ 8.88% YoYΔ $5.46M vs prior year quarter

Peer trimmed avg / median

Loading

General Biologicals Accounts Payable History

Loading

General Biologicals vs. peers: Accounts Payable Comparison

Loading

General Biologicals Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

General Biologicals (4117.TWO) FAQ

General Biologicals (4117.TWO) currently reports a accounts payable of $67M as of June 2026. That compares with $62M in the prior-year period — up 8.9% year over year. Use the charts on this page to explore General Biologicals's accounts payable history and peer comparisons.

General Biologicals's accounts payable increased from $62M to $67M — a 8.9% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

General Biologicals reported $67M in accounts payable as of June 2026. That compares with $62M in the prior-year period — up 8.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $67M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for General Biologicals, and consider following 4117.TWO for alerts when major investors trade the stock.